Evidence map›Paper›PMID 29390862›Full record

Trial reportAmerican journal of health promotion : AJHP2018

Financial Incentives for Chronic Disease Management: Results and Limitations of 2 Randomized Clinical Trials With New York Medicaid Patients.

Eric M VanEpps, Andrea B Troxel, Elizabeth Villamil, Kathryn A Saulsgiver, Jingsan Zhu, Jo-Yu Chin, Jacqueline Matson, Joseph Anarella, Patrick Roohan, Foster Gesten and 1 more

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in American journal of health promotion : AJHP, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Study design of BETTER-BP: Behavioral economics trial to enhance regulation of blood pressure.International journal of cardiology. Cardiovascular risk and prevention · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Eric M VanEpps1 David Eccles School of Business, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-9454-4847
Andrea B Troxel2 Department of Population Health, New York University School of Medicine, New York, NY, USA.
Elizabeth Villamil3 New York State Department of Health, Albany, NY, USA.
Kathryn A Saulsgiver4 Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.
Jingsan Zhu4 Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.
Jo-Yu Chin3 New York State Department of Health, Albany, NY, USA.
Jacqueline Matson3 New York State Department of Health, Albany, NY, USA.
Joseph Anarella6 Consultant, Albany, NY, USA.
Patrick Roohan7 MVP Health Care, Schenectady, NY, USA.
Foster Gesten3 New York State Department of Health, Albany, NY, USA.
Kevin G Volpp4 Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.
New York State Department of Health · USUniversity of Pennsylvania · USNew York University · USPhiladelphia VA Medical Center · USUniversity of Utah · US

Funding

The Penn Roybal Center on Behavioral Economics and Health: Solving for Scale and Impact with Design Thinking, Digital Platforms, and Dynamic AdaptationP30AG034546 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Alison Meredith Buttenheim, KEVIN G VOLPP · 2009 to 2026
$10.6M
NIA NIH HHS P30 AG034546
6 · The paper itself

Abstract

purposeTo identify whether financial incentives promote improved disease management in Medicaid recipients diagnosed with hypertension or diabetes, respectively.

designFour-group, multicenter, randomized clinical trials. SETTING AND

participantsBetween 2013 and 2016, New York State Medicaid managed care members diagnosed with hypertension (N = 920) or with diabetes (N = 959).

interventionParticipants in each 6-month trial were randomly assigned to 1 of 4 arms: (1) process incentives-earned by attending primary care visits and/or receiving prescription medication refills, (2) outcome incentives-earned by reducing systolic blood pressure (hypertension) or hemoglobin A MEASURES: Systolic blood pressure (hypertension) and HbA

conclusionFinancial incentives-regardless of whether they were delivered based on disease-relevant outcomes, process activities, or a combination of the two-have a negligible impact on health outcomes for Medicaid recipients diagnosed with either hypertension or diabetes in 2 studies in which, among other design and operational limitations, the majority of recipients had relatively well-controlled diseases at the time of enrollment.

Indexed as

Disease ManagementMotivationAdultDiabetes MellitusFemaleHumansHypertensionMaleMedicaidMedication AdherenceMiddle AgedNew YorkPatient Acceptance of Health CarePopulation HealthReimbursement, IncentiveUnited Statesdiabetesfinancial incentiveshypertensionincentivesinterventionsmedicaidmotivationoutcomespopulation healthprocessstrategies

Identifiers

PMID29390862
PMCPMC7256969
OpenAlexW2787089569

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.